Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07324408. HopeStage can help you review the study, but cannot decide medical eligibility.
CompletedNCT07324408
Multiple Ascending Dose Study of NH102 in Healthy Subjects
This study is completed. It focuses on depression and currently lists study information in China.
DepressionOtherFrom 18 Years to 45 Years
Key information made simple
This study exists to better understand the safety of the medication NH102 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication NH102 in practice and what may need to be adjusted. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.
Your next step
The official record suggests in-person participation through a research setting, with sites including Shanghai Mental Health Center. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Sponsor type
- Pharmaceutical company
- Main activity
- medication or study treatment
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Completed
- Source
- Official registry link
Key study information
- Official title
- Multiple Ascending Dose Study of NH102 in Healthy Subjects
- Condition
- Depression
- Study status
- Completed
- Sponsor / lead affiliation
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
- Location / country
- China
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07324408
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in China.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Multiple Ascending Dose Study of NH102 in Healthy Subjects
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07324408
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Multiple Ascending Dose Study of NH102 in Healthy Subjects?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Jiangsu Nhwa Pharmaceutical Co., Ltd.. Based on the sponsor name or official registry information, it appears to be a pharmaceutical company. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me